Background Image
Table of Contents Table of Contents
Previous Page  85 / 124 Next Page
Information
Show Menu
Previous Page 85 / 124 Next Page
Page Background

85

Food and Drug Administration

4. Establishment of Technology and Database for Drug Abuse

In response to the deteriorating drug abuse and addiction issues, TFDA continues to

dedicate the developing new technology and establishing database to achieve the

prevention effectively and control of drug abuse. Important outcomes are shown as in

Table 9-6.

Section 4 Nanotechnology Product Policy and Management

Research

States

Nanotechnology is the new 21

st

Century trend. The TFDA sets policies for nanotechnology

research and application guidelines including all the correlated byproduct manufacture,

risk factor evaluation and monitoring system management to assure the product safety

and quality control.

Policy and Outcome

1. Establishment of Exceptional Rule and Regulation Management for Nano

Biomedical Products

(1) In 2013, 8 nanotechnology byproduct conferences were held including 2 for the

nanotechnology drug policy, 3 for nanotechnology medical equipment policy, risk

factors and experts, 1 for professional experts in nanotechnology cosmetics, and 2

Table 9-6 Important outcomes for the establishment of test technology and data for

drug abuse prevention and control in 2013

Outcome

Effectiveness

Completed the synthesis of 12 standard items and

the establishment of standard spectrum database

of H

1

, C

13

-NMR, FTIR, GC-MS and HRMS

To meet the test demands, which the

synthetic standards are not commercially

available for abused drugs in Taiwan

Completed the optical spectrum conditions of 191

standard items (including amphetamine, cathinone,

tryptamines, opium, marijuana, active substances of

marijuana, cocaine, and benzodiazepines) as well as

secondary fragment mass spectrometry database

To prevent and control drug abuse, quickly

screening known and unknown abused

drugs

Completed the discussion on optimal ionization

conditions and spectrum linkage conditions of 35

substances contained in urine

Speeded up the time effectiveness of

abused drugs and commanded the trend of

drug abuse

Development the pre-treatment method and GS/

MS instrument spectrum test methods for synthetic

cathinones in urine

Provide as the reference method for the

private labs to command the prevalent trend

of synthetic cathinones